Stage IV Salivary Gland Cancer Completed Phase 1 Trials for Motolimod (DB12303)

Also known as: Salivary gland cancer stage IV / Metastatic salivary gland cancer / Malignant salivary gland cancer stage IV

IndicationStatusPhase
DBCOND0028780 (Stage IV Salivary Gland Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01334177TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckTreatment